CALGB 80802

Department: 
Oncology
Diagnosis: 
Gastrointestinal - Liver
Sponsor: 
CALGB
Indentifier #: 
NCT01015833
Title: 
CALGB 80802, Phase III Randomized Study of Sorafenib Plus Doxorubicin Versus Sorafenib In Patients with Advanced Hepatocellular Carcinoma (HCC)